Study of Paclitaxel, Etoposide, and Cisplatin Chemotherapy Combined With Twice-Daily Thoracic Radiotherapy for Patients With Limited-Stage Small-Cell Lung Cancer: A Radiation Therapy Oncology Group 9609 Phase II Study

Small Cell ◽

Oncology Group ◽

Thoracic Radiotherapy ◽

P-774 Phase II study of cisplatin plus etoposide with concurrent thoracic radiotherapy (TRT) followed by innotecan plus cisplatin in limited stage small-cell lung cancer (SCLC); A West Japan Thoracic Oncology Group Trial

Lung Cancer ◽

10.1016/s0169-5002(05)81267-x ◽

2005 ◽

Vol 49 ◽

pp. S322 ◽

Cited By ~ 1

Author(s):

T. Kashii ◽

H. Saito ◽

S. Negoro ◽

Y. Takada ◽

Y. Ichinose ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Small Cell ◽

Oncology Group ◽

Thoracic Radiotherapy ◽

Small Cell Lung ◽

Group Trial

Etoposide, ifosfamide and cisplatin (VIP) plus concurrent radiation therapy for previously untreated limited small cell lung cancer (SCLC): a Hoosier Oncology Group (HOG) phase II study

Lung Cancer ◽

10.1016/s0169-5002(01)00429-9 ◽

2002 ◽

Vol 35 (3) ◽

pp. 293-297 ◽

Cited By ~ 15

Author(s):

Nasser Hanna ◽

Rafat Ansari ◽

William Fisher ◽

Jianzhao Shen ◽

Sin-Ho Jung ◽

...

Keyword(s):

Lung Cancer ◽

Radiation Therapy ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Small Cell ◽

Oncology Group ◽

Phase II Study of Etoposide and Cisplatin With Concurrent Twice-Daily Thoracic Radiotherapy Followed by Irinotecan and Cisplatin in Patients With Limited-Disease Small-Cell Lung Cancer: West Japan Thoracic Oncology Group 9902

Yearbook of Oncology ◽

10.1016/s1040-1741(08)79221-2 ◽

2008 ◽

Vol 2008 ◽

pp. 171-173

Author(s):

N.H. Hanna

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Small Cell ◽

Oncology Group ◽

Thoracic Radiotherapy ◽

Small Cell Lung ◽

Limited Disease

Phase II Study of Accelerated High-Dose Radiotherapy With Concurrent Chemotherapy for Patients With Limited Small-Cell Lung Cancer: Radiation Therapy Oncology Group Protocol 0239

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2012.01.075 ◽

2012 ◽

Vol 83 (4) ◽

pp. e531-e536 ◽

Cited By ~ 25

Author(s):

Ritsuko Komaki ◽

Rebecca Paulus ◽

David S. Ettinger ◽

Gregory M.M. Videtic ◽

Jeffrey D. Bradley ◽

...

Keyword(s):

Lung Cancer ◽

Radiation Therapy ◽

Small Cell Lung Cancer ◽

Phase Ii Study ◽

Concurrent Chemotherapy ◽

Small Cell ◽

High Dose ◽

Oncology Group ◽

Amifostine as mucosal protectant in patients with locally advanced non-small cell lung cancer (NSCLC) receiving intensive chemotherapy and thoracic radiotherapy (RT): results of the radiation therapy oncology group (RTOG) 98–01 study

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/s0360-3016(03)01029-0 ◽

2003 ◽

Vol 57 (2) ◽

pp. S216 ◽

Cited By ~ 18

Author(s):

M Werner-Wasik ◽

C Scott ◽

B Movsas ◽

C Langer ◽

L Sarna ◽

...

Keyword(s):

Lung Cancer ◽

Radiation Therapy ◽

Small Cell Lung Cancer ◽

Locally Advanced ◽

Small Cell ◽

Intensive Chemotherapy ◽

Oncology Group ◽

Thoracic Radiotherapy ◽

Phase II trial of combination chemotherapy and irradiation in non-small-cell lung cancer, Radiation Therapy Oncology Group 88-04

Lung Cancer ◽

10.1016/0169-5002(93)90596-p ◽

1993 ◽

Vol 8 (5-6) ◽

pp. 349

Keyword(s):

Lung Cancer ◽

Radiation Therapy ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Combination Chemotherapy ◽

Phase Ii Trial ◽

Small Cell ◽

Oncology Group ◽

266 A phase II study of VP-16 plus ifosfamide plus cisplatin (VIP) plus concurrent radiation therapy (XRT) for previously untreated limited small cell lung cancer (SCLC): A Hoosier Oncology Group (HOG) trial

Lung Cancer ◽

10.1016/s0169-5002(97)89649-3 ◽

1997 ◽

Vol 18 ◽

pp. 70

Author(s):

A.B. Sandler ◽

R. Ansari ◽

W. Fisher ◽

R. Gonin ◽

R. Levy ◽

...

Keyword(s):

Lung Cancer ◽

Radiation Therapy ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Small Cell ◽

Oncology Group ◽

A Phase II Study of Paclitaxel + Etoposide + Cisplatin + Concurrent Radiation Therapy for Previously Untreated Limited Stage Small Cell Lung Cancer (E2596): A Trial of the Eastern Cooperative Oncology Group

Journal of Thoracic Oncology ◽

10.1097/jto.0b013e31819c7daf ◽

2009 ◽

Vol 4 (4) ◽

pp. 527-533 ◽

Cited By ~ 10

Author(s):

Leora Horn ◽

Patricia Bernardo ◽

Alan Sandler ◽

Henry Wagner ◽

Nathan Levitan ◽

...

Keyword(s):

Lung Cancer ◽

Radiation Therapy ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Eastern Cooperative Oncology Group ◽

Small Cell ◽

Oncology Group ◽

Phase II Trial of Combination Chemotherapy and Irradiation in Non-Small-Cell Lung Cancer, Radiation Therapy Oncology Group 88–04

American Journal of Clinical Oncology ◽

10.1097/00000421-199204000-00014 ◽

1992 ◽

Vol 15 (2) ◽

pp. 163-167 ◽

Cited By ~ 36

Author(s):

William T. Sause ◽

Charles Scott ◽

Samuel Taylor ◽

Roger W. Byhardt ◽

Franklin L. Banker ◽

...

Keyword(s):

Lung Cancer ◽

Radiation Therapy ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Combination Chemotherapy ◽

Phase Ii Trial ◽

Small Cell ◽

Oncology Group ◽

Phase II Study of Neoadjuvant Concurrent Chemo-immuno-radiation Therapy Followed by Surgery and Adjuvant Immunotherapy for Resectable Stage IIIA-B (Discrete N2) Non-Small Cell Lung Cancer: SQUAT trial (WJOG 12119L)

Clinical Lung Cancer ◽

10.1016/j.cllc.2021.04.006 ◽

2021 ◽

Author(s):

Akira Hamada ◽

Junichi Soh ◽

Akito Hata ◽

Kiyoshi Nakamatsu ◽

Mototsugu Shimokawa ◽

...

Keyword(s):

Lung Cancer ◽

Radiation Therapy ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Small Cell ◽

Small Cell Lung ◽

Stage Iiia ◽

Adjuvant Immunotherapy